Thank you @vpd-hlri.bsky.social for the shout-out.
Original article here:
rdcu.be/eX8W3

The IVORY trial was published in Nature Medicine last week. rdcu.be/eX8W3

This trial done in high-risk individuals who presented with heart attacks 🫀, showed low-dose interleukin-2 led to a
⬆️ Regulatory T cells
⬇️ Arterial inflammation 🔥
⬇️ trend in adverse cardiovascular outcomes ❤️‍🔥 at 2 years